Lehrstuhl für Urologie

Krankenhausstraße 12
91054 Erlangen

Untergeordnete Organisationseinheiten

Professur für Molekulare Urologie
Scholz-Stiftungsprofessur für Kinderurologie

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 7 Go to next page Go to last page

Wach, S., Brandl, M., Borchardt, H., Weigelt, K., Lukat, S., Nolte, E.,... Aigner, A. (2019). Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Therapy - Nucleic Acids, 16, 272-283. https://dx.doi.org/10.1016/j.omtn.2019.02.020
Stoehr, R., Wendler, O.D., Giedl, J., Gaisa, N.T., Richter, G., Campean, V.,... Hartmann, A. (2019). No Evidence of Microsatellite Instability and Loss of Mismatch-Repair-Protein Expression in Squamous Cell Carcinoma of the Penis. Pathobiology, 86(2-3), 145-151. https://dx.doi.org/10.1159/000495251
Taubert, H., Becker, C., Fuessel, S., Seitz, G., Kristiansen, G., Wach, S., & Wullich, B. (2019). The 16th DPKK Annual Conference "Urology meets Pathology". Urologe, 58(6), 686-689. https://dx.doi.org/10.1007/s00120-019-0941-2
Eckstein, M., Sailer, V., Nielsen, B.S., Wittenberg, T., Wiesmann, V., Lieb, V.,... Wach, S. (2019). Co-staining of microRNAs and their target proteins by miRNA in situ hybridization and immunohistofluorescence on prostate cancer tissue microarrays. Laboratory Investigation. https://dx.doi.org/10.1038/s41374-019-0251-8
Kahlmeyer, A., Stoehr, C.G., Hartmann, A., Goebell, P., Wullich, B., Wach, S.,... Erlmeier, F. (2019). Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma. Journal of Clinical Medicine, 8(5). https://dx.doi.org/10.3390/jcm8050743
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments (Assessments vor Operationen). Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Kahlmeyer, A., Goebell, P., & Wullich, B. (2019). Presurgical assessments. Urologe, 58(4), 373-380. https://dx.doi.org/10.1007/s00120-019-0888-3
Wullich, B., & Wiedemann, A. (2019). Geriatric urology (Geriatrische Urologie). Urologe, 58(4), 369-. https://dx.doi.org/10.1007/s00120-019-0912-7
Williams, S.B., Hudgins, H.K., Ray-Zack, M.D., Chamie, K., Smaldone, M.C., Boorjian, S.A.,... Gore, J.L. (2019). Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer. European Urology Oncology, 2(2), 119-125. https://dx.doi.org/10.1016/j.euo.2018.07.006
Govers, T.M., Hessels, D., Vlaeminck-Guillem, V., Schmitz-Draeger, B.J., Stief, C.G., Martinez-Ballesteros, C.,... Schalken, J.A. (2019). Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study. Prostate Cancer and Prostatic Diseases, 22(1), 101-109. https://dx.doi.org/10.1038/s41391-018-0076-3
Stoehr, C.G., Steffens, S., Polifka, I., Jung, R., Kahlmeyer, A., Ivanyi, P.,... Taubert, H. (2019). Piwi-like 1 protein expression is a prognostic factor for renal cell carcinoma patients. Scientific Reports, 9. https://dx.doi.org/10.1038/s41598-018-38254-3
Erben, P., Sikic, D., Wirtz, R.M., Martini, T., Weis, C.-A., Breyer, J.,... Bolenz, C. (2019). Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder. Virchows Archiv, 474(2), 209–217. https://dx.doi.org/10.1007/s00428-018-2496-9
Cebulla, A., Bolenz, C., Carrion, D.M., & Bellut, L. (2019). Urology training in Germany: international comparison of educational concepts and satisfaction Urologische Facharztausbildung im internationalen Vergleich: Wo stehen wir in Deutschland? Urologe, 58(2), 132-138. https://dx.doi.org/10.1007/s00120-019-0854-0
Cebulla, A., Bolenz, C., Carrion, D.M., & Bellut, L. (2019). Urology training in Germany: international comparison of educational concepts and satisfaction. Urologe, 58(2), 132-138. https://dx.doi.org/10.1007/s00120-019-0854-0
Kunath, F., Goebell, P., Wullich, B., Sikic, D., & Kahlmeyer, A. (2019). Timing of androgen deprivation monotherapy and combined treatments in castration-sensitive and castration-resistant prostate cancer: a narrative review. World Journal of Urology. https://dx.doi.org/10.1007/s00345-019-02704-y
Boormans, J.L., Zwarthoff, E.C., Black, P.C., Goebell, P., Kamat, A.M., Nawroth, R.,... Schmitz-Dräger, B.J. (2019). New horizons in bladder cancer research. Urologic Oncology-Seminars and Original Investigations. https://dx.doi.org/10.1016/j.urolonc.2018.12.014
Polifka, I., Agaimy, A., Herrmann, E., Spath, V., Trojan, L., Stoeckle, M.,... Hartmann, A. (2019). High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma. Human Pathology, 83, 212-223. https://dx.doi.org/10.1016/j.humpath.2018.08.006
Eckstein, M., Erben, P., Kriegmair, M.C., Worst, T.S., Weiss, C.-A., Wirtz, R.M.,... Erlmeier, F. (2019). Performance of the Food and Drug Administration/EMA-approved programmed cell death ligand-1 assays in urothelial carcinoma with emphasis on therapy stratification for first-line use of atezolizumab and pembrolizumab. European journal of cancer, 106, 234-243. https://dx.doi.org/10.1016/j.ejca.2018.11.007
Schmidkonz, C., Cordes, M., Beck, M., Goetz, T.I., Schmidt, D., Prante, O.,... Ritt, P. (2018). SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer. Clinical Nuclear Medicine. https://dx.doi.org/10.1097/RLU.0000000000001991
Eckstein, M., Wirtz, R.M., Pfannstil, C., Wach, S., Stoehr, R., Breyer, J.,... Erben, P. (2018). A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy. Oncotarget, 9(19), 15001-15014. https://dx.doi.org/10.18632/oncotarget.24531

Zuletzt aktualisiert 2019-24-04 um 10:30